Streamlining European Expansion With Integrated PV, Regulatory, And Commercial Expertise

A U.S.-based biopharmaceutical company with a limited European footprint was preparing to launch an orphan medicinal product for a rare disease across key markets, including Germany, France, Italy, Spain, and the United Kingdom. With plans to expand further within Europe, the company required strategic guidance to manage the complexities of a multi-country launch — ranging from launch sequencing and importation logistics to market access, supply chain design, and alignment of regulatory and pharmacovigilance activities.

Given the need to meet stringent health authority requirements and ensure patient safety across multiple jurisdictions, pharmacovigilance was a central pillar of the launch strategy. To support a coordinated and efficient approach, the company sought a single, globally capable partner able to deliver integrated pharmacovigilance services at the global, regional, and local levels throughout the product lifecycle.